Navigation Links
Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
Date:9/8/2009

neinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the standard carboplatin and paclitaxel response rate will not be improved as a result of the combination therapy and the risk that the results of the subsequent stage for this trial will not be consistent with the results of the first stage. Factors that could cause actual results to differ materially or otherwise adversely impact the company's ability to obtain regulatory approval for its product candidates include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2009 and the quarterly report on Form 10-Q for the quarter ended July 31, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Phar
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
7. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Can economic ... from work motivate members of the public to increase ... including Johns Hopkins Carey Business School Assistant ... yes. Pointing to a large body of recent research ... the May 24, 2013, issue of Science that the ...
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... -- Z Trim Holdings, Inc. (OTC Markets: ZTHO), a ... industries, announced that Chef Erin Ryan ... National Restaurant Association ("NRA") NRA Show, which was held ... Chefs Association.  Chef Ryan spoke on the subject of ... the Ugly," joining four other prestigious panelists including:  Kit ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... -- China Medicine Corporation,(OTC Bulletin Board: CHME) ... and distributor of prescription and over the ... dietary supplements, and,medical devices and medical formulations ... (Good Supply Practice for Pharmaceutical Products) certification,from ...
... HANGZHOU, China, Dec. 1 /PRNewswire-Asia/ -- Tigermed ... (CRO) in China, announced that it has,established ... Ltd, with Central, South University (CSU). ... participation in the construction of a nationwide ...
... Inc.,(Nasdaq: NVAX ) a clinical-stage vaccine company, ... Officer, will be presenting at,the Piper Jaffray 20th Annual ... in New York. Dr. Singhvi will provide an overview ... to the live,presentation can be accessed via the Company ...
Cached Biology Technology:China Medicine Corporation Awarded GSP Certification 2China Medicine Corporation Awarded GSP Certification 3Tigermed Sets Up Subsidiary, Hunan Tigermed Xiangya Drug R&D Ltd (Tigermed Xiangya) 2
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
(Date:5/22/2013)... human health effects from disposal of millions of ... to recommend stronger government policies to encourage recovery, ... That,s the conclusion of a new paper in ... . , Oladele A. Ogunseitan and colleagues point ... powering everything from smart phones to components in ...
(Date:5/22/2013)... Declines in the biodiversity of pollinating insects and wild ... new study. , Researchers led by the University of ... found evidence of dramatic reductions in the diversity ... the 1950s and 1980s. , But the picture brightened ... national biodiversity losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... of locally and regionally grown food is on the ... for those with limited financial resources. Virginia Tech,s College ... Virginia University and North Carolina State University to develop, ... the resiliency of the Southern Appalachian region, with a ...
... in New Zealand have identified the direct impact of ... decline of the endangered native sea lion population. The ... non-human factors, such as disease and identifies resource competition ... The New Zealand sea lion Phocarctos hookeri is the ...
... of molecular scientists have discovered that star ascidians, also known ... the human heart. The research, published in the JEZ ... insight into the early evolution of the heart as star ... The research team, led by Annette Hellbach from the ...
Cached Biology News:Virginia Tech leads study to improve food security in southern Appalachia 2Virginia Tech leads study to improve food security in southern Appalachia 3Competition with humans responsible for decline of New Zealand's endangered sea lions, study shows 2Sea squirt pacemaker gives new insight into evolution of the human heart 2
... LV Series offers high performance miniature stepper ... 23, and 34 frame sizes. These space-efficient ... life science applications, including medical instrumentation, medical ... automation systems., Meets a wide range ...
... nitrogen base (YNB) is a base medium for ... YNB contains ammonium sulfate but does not contain ... are available. Each pouch contains reagents to ... media or 1000 ml of 10X YNB for ...
... Designed for use with dishes and cell ... a new product number, created to easily ... availability yet, please order under the old ... for assistance. Comp Dim: blade L 1.9 ...
... CHEMICONs Alkaline Phosphatase Detection Kit (Catalog number ... for the phenotypic assessment of ES cell ... Available separately from CHEMICON are the ... TRA-2-54 (Catalog Number MAB4354), which permit the ...
Biology Products: